US Stock MarketDetailed Quotes

ARAY Accuray

Watchlist
  • 2.110
  • +0.150+7.65%
Close Nov 27 16:00 ET
  • 2.110
  • 0.0000.00%
Post 20:01 ET
212.19MMarket Cap-12411P/E (TTM)

Accuray Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.10%-7.29M
-176.61%-11.9M
11.27%9.88M
-132.90%-8.1M
71.73%-5.09M
-18,776.09%-8.59M
747.46%15.54M
291.24%8.88M
213.13%24.63M
-155.24%-18.01M
Net income from continuing operations
-33.18%-3.95M
-67.51%-15.55M
232.51%3.39M
-1,158.76%-6.34M
-413.39%-9.62M
45.51%-2.97M
-73.56%-9.28M
25.96%-2.56M
157.27%599K
-1,146.93%-1.87M
Operating gains losses
220.96%3.69M
193.65%2.27M
139.89%1.14M
313.33%1.43M
-342.64%-1.44M
181.17%1.15M
-178.56%-2.43M
-1,141.24%-2.85M
-47.57%345K
-692.73%-326K
Depreciation and amortization
17.03%1.46M
30.44%5.91M
37.37%1.51M
45.15%1.6M
34.32%1.55M
6.38%1.25M
-17.88%4.53M
-13.55%1.1M
-21.38%1.1M
-19.06%1.15M
Deferred tax
-111.72%-75K
207.46%1.4M
----
----
----
--640K
-74.45%456K
----
----
----
Other non cash items
6.72%254K
3.13%955K
2.52%244K
-2.07%236K
3.95%237K
8.68%238K
13.34%926K
6.73%238K
12.09%241K
2.24%228K
Change In working capital
3.21%-12.18M
-574.13%-21.92M
-133.29%-1.85M
-142.77%-8.84M
106.25%1.35M
-43,506.90%-12.59M
120.46%4.62M
168.36%5.54M
177.91%20.66M
-179.74%-21.61M
-Change in receivables
138.54%2M
-185.60%-15.83M
-3,571.16%-17.7M
-83.22%2.23M
149.56%4.84M
-133.60%-5.2M
247.68%18.49M
93.90%-482K
275.40%13.27M
-180.49%-9.77M
-Change in inventory
-90.48%-16.99M
41.68%-4M
597.91%18.67M
-270.51%-8.03M
-204.14%-5.72M
27.83%-8.92M
70.01%-6.86M
138.18%2.68M
130.76%4.71M
-221.97%-1.88M
-Change in prepaid assets
251.15%3.67M
251.53%6.11M
-12.42%1.68M
191.30%3.16M
1,312.13%3.7M
-11.22%-2.43M
33.32%-4.03M
156.62%1.92M
-93.83%-3.46M
-149.59%-305K
-Change in payables and accrued expense
-235.30%-5.64M
-77.01%859K
-134.38%-2.19M
13.20%2.78M
58.12%-3.9M
-1.30%4.17M
-79.65%3.74M
-26.92%6.37M
181.26%2.46M
-181.68%-9.31M
-Change in other current liabilities
----
199.07%321K
----
----
----
----
63.18%-324K
----
----
----
-Change in other working capital
2,337.56%4.77M
-46.70%-9.38M
42.96%-2.63M
-343.10%-8.97M
790.08%2.44M
95.84%-213K
-576.45%-6.39M
-372.52%-4.61M
103.14%3.69M
-129.32%-353K
Cash from discontinued investing activities
Operating cash flow
15.10%-7.29M
-176.61%-11.9M
11.27%9.88M
-132.90%-8.1M
71.73%-5.09M
-18,776.09%-8.59M
747.46%15.54M
291.24%8.88M
213.13%24.63M
-155.24%-18.01M
Investing cash flow
Cash flow from continuing investing activities
-2.56%-1.12M
71.60%-3.6M
94.17%-465K
58.14%-795K
18.58%-1.25M
14.15%-1.09M
-168.84%-12.68M
-471.35%-7.98M
-78.81%-1.9M
-91.03%-1.53M
Net PPE purchase and sale
-2.56%-1.12M
71.45%-3.6M
94.21%-465K
55.98%-795K
16.79%-1.25M
14.15%-1.09M
-167.42%-12.61M
-475.57%-8.04M
-70.06%-1.81M
-86.92%-1.5M
Net intangibles purchase and sale
----
--0
--0
--0
----
----
---67K
--0
---34K
----
Cash from discontinued investing activities
Investing cash flow
-2.56%-1.12M
71.60%-3.6M
94.17%-465K
58.14%-795K
18.58%-1.25M
14.15%-1.09M
-168.84%-12.68M
-471.35%-7.98M
-78.81%-1.9M
-91.03%-1.53M
Financing cash flow
Cash flow from continuing financing activities
-44.87%-2.17M
-87.07%-3.95M
-32.95%-694K
0.00%-1.5M
-106.01%-257K
65.64%-1.5M
86.26%-2.11M
-470.21%-522K
-50.00%-1.5M
131.64%4.28M
Net issuance payments of debt
-33.33%-2M
-55.24%-6M
0.00%-1.5M
0.00%-1.5M
-142.86%-1.5M
65.64%-1.5M
79.66%-3.87M
-50.00%-1.5M
-50.00%-1.5M
121.88%3.5M
Net common stock issuance
----
2.14%2.25M
----
----
----
----
-43.43%2.2M
----
----
----
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
--0
----
Net other financing activities
---173K
55.70%-198K
2.41%-81K
--0
----
----
-73.26%-447K
---83K
--0
----
Cash from discontinued financing activities
Financing cash flow
-44.87%-2.17M
-87.07%-3.95M
-32.95%-694K
0.00%-1.5M
-106.01%-257K
65.64%-1.5M
86.26%-2.11M
-470.21%-522K
-50.00%-1.5M
131.64%4.28M
Net cash flow
Beginning cash position
-22.82%70.39M
1.16%91.2M
-31.59%62.15M
7.63%74.49M
-4.49%78.69M
1.16%91.2M
-23.73%90.15M
-8.50%90.85M
-44.50%69.21M
-22.63%82.39M
Current changes in cash
5.33%-10.59M
-2,708.04%-19.46M
2,177.55%8.72M
-148.98%-10.4M
56.79%-6.6M
-100.02%-11.18M
103.32%746K
106.49%383K
189.08%21.23M
-183.47%-15.27M
Effect of exchange rate changes
199.92%1.33M
-548.34%-1.35M
-1,464.52%-485K
-571.12%-1.94M
14.61%2.4M
38.89%-1.33M
105.43%302K
99.04%-31K
126.09%412K
2,351.61%2.09M
End cash Position
-22.31%61.13M
-22.82%70.39M
-22.82%70.39M
-31.59%62.15M
7.63%74.49M
-4.49%78.69M
1.16%91.2M
1.16%91.2M
-8.50%90.85M
-44.50%69.21M
Free cash flow
13.11%-8.41M
-642.51%-15.51M
1,013.12%9.42M
-139.05%-8.9M
67.56%-6.34M
-689.80%-9.68M
140.16%2.86M
114.01%846K
199.81%22.79M
-161.46%-19.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.10%-7.29M-176.61%-11.9M11.27%9.88M-132.90%-8.1M71.73%-5.09M-18,776.09%-8.59M747.46%15.54M291.24%8.88M213.13%24.63M-155.24%-18.01M
Net income from continuing operations -33.18%-3.95M-67.51%-15.55M232.51%3.39M-1,158.76%-6.34M-413.39%-9.62M45.51%-2.97M-73.56%-9.28M25.96%-2.56M157.27%599K-1,146.93%-1.87M
Operating gains losses 220.96%3.69M193.65%2.27M139.89%1.14M313.33%1.43M-342.64%-1.44M181.17%1.15M-178.56%-2.43M-1,141.24%-2.85M-47.57%345K-692.73%-326K
Depreciation and amortization 17.03%1.46M30.44%5.91M37.37%1.51M45.15%1.6M34.32%1.55M6.38%1.25M-17.88%4.53M-13.55%1.1M-21.38%1.1M-19.06%1.15M
Deferred tax -111.72%-75K207.46%1.4M--------------640K-74.45%456K------------
Other non cash items 6.72%254K3.13%955K2.52%244K-2.07%236K3.95%237K8.68%238K13.34%926K6.73%238K12.09%241K2.24%228K
Change In working capital 3.21%-12.18M-574.13%-21.92M-133.29%-1.85M-142.77%-8.84M106.25%1.35M-43,506.90%-12.59M120.46%4.62M168.36%5.54M177.91%20.66M-179.74%-21.61M
-Change in receivables 138.54%2M-185.60%-15.83M-3,571.16%-17.7M-83.22%2.23M149.56%4.84M-133.60%-5.2M247.68%18.49M93.90%-482K275.40%13.27M-180.49%-9.77M
-Change in inventory -90.48%-16.99M41.68%-4M597.91%18.67M-270.51%-8.03M-204.14%-5.72M27.83%-8.92M70.01%-6.86M138.18%2.68M130.76%4.71M-221.97%-1.88M
-Change in prepaid assets 251.15%3.67M251.53%6.11M-12.42%1.68M191.30%3.16M1,312.13%3.7M-11.22%-2.43M33.32%-4.03M156.62%1.92M-93.83%-3.46M-149.59%-305K
-Change in payables and accrued expense -235.30%-5.64M-77.01%859K-134.38%-2.19M13.20%2.78M58.12%-3.9M-1.30%4.17M-79.65%3.74M-26.92%6.37M181.26%2.46M-181.68%-9.31M
-Change in other current liabilities ----199.07%321K----------------63.18%-324K------------
-Change in other working capital 2,337.56%4.77M-46.70%-9.38M42.96%-2.63M-343.10%-8.97M790.08%2.44M95.84%-213K-576.45%-6.39M-372.52%-4.61M103.14%3.69M-129.32%-353K
Cash from discontinued investing activities
Operating cash flow 15.10%-7.29M-176.61%-11.9M11.27%9.88M-132.90%-8.1M71.73%-5.09M-18,776.09%-8.59M747.46%15.54M291.24%8.88M213.13%24.63M-155.24%-18.01M
Investing cash flow
Cash flow from continuing investing activities -2.56%-1.12M71.60%-3.6M94.17%-465K58.14%-795K18.58%-1.25M14.15%-1.09M-168.84%-12.68M-471.35%-7.98M-78.81%-1.9M-91.03%-1.53M
Net PPE purchase and sale -2.56%-1.12M71.45%-3.6M94.21%-465K55.98%-795K16.79%-1.25M14.15%-1.09M-167.42%-12.61M-475.57%-8.04M-70.06%-1.81M-86.92%-1.5M
Net intangibles purchase and sale ------0--0--0-----------67K--0---34K----
Cash from discontinued investing activities
Investing cash flow -2.56%-1.12M71.60%-3.6M94.17%-465K58.14%-795K18.58%-1.25M14.15%-1.09M-168.84%-12.68M-471.35%-7.98M-78.81%-1.9M-91.03%-1.53M
Financing cash flow
Cash flow from continuing financing activities -44.87%-2.17M-87.07%-3.95M-32.95%-694K0.00%-1.5M-106.01%-257K65.64%-1.5M86.26%-2.11M-470.21%-522K-50.00%-1.5M131.64%4.28M
Net issuance payments of debt -33.33%-2M-55.24%-6M0.00%-1.5M0.00%-1.5M-142.86%-1.5M65.64%-1.5M79.66%-3.87M-50.00%-1.5M-50.00%-1.5M121.88%3.5M
Net common stock issuance ----2.14%2.25M-----------------43.43%2.2M------------
Proceeds from stock option exercised by employees --------------0------------------0----
Net other financing activities ---173K55.70%-198K2.41%-81K--0---------73.26%-447K---83K--0----
Cash from discontinued financing activities
Financing cash flow -44.87%-2.17M-87.07%-3.95M-32.95%-694K0.00%-1.5M-106.01%-257K65.64%-1.5M86.26%-2.11M-470.21%-522K-50.00%-1.5M131.64%4.28M
Net cash flow
Beginning cash position -22.82%70.39M1.16%91.2M-31.59%62.15M7.63%74.49M-4.49%78.69M1.16%91.2M-23.73%90.15M-8.50%90.85M-44.50%69.21M-22.63%82.39M
Current changes in cash 5.33%-10.59M-2,708.04%-19.46M2,177.55%8.72M-148.98%-10.4M56.79%-6.6M-100.02%-11.18M103.32%746K106.49%383K189.08%21.23M-183.47%-15.27M
Effect of exchange rate changes 199.92%1.33M-548.34%-1.35M-1,464.52%-485K-571.12%-1.94M14.61%2.4M38.89%-1.33M105.43%302K99.04%-31K126.09%412K2,351.61%2.09M
End cash Position -22.31%61.13M-22.82%70.39M-22.82%70.39M-31.59%62.15M7.63%74.49M-4.49%78.69M1.16%91.2M1.16%91.2M-8.50%90.85M-44.50%69.21M
Free cash flow 13.11%-8.41M-642.51%-15.51M1,013.12%9.42M-139.05%-8.9M67.56%-6.34M-689.80%-9.68M140.16%2.86M114.01%846K199.81%22.79M-161.46%-19.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday+1.05%